Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Si-Bone (SIBN) EPS (Weighted Average and Diluted) (2020 - 2026)

Si-Bone's quarterly EPS (Weighted Average and Diluted) came in at -$0.1 in Q1 2026, up 33.33% year-on-year from -$0.08 in Q1 2025, and down 150.0% quarter-over-quarter from -$0.04 in Q4 2025.

Si-Bone has reported EPS (Weighted Average and Diluted) for 7 years, with the latest figure at -$0.1 in Q1 2026.

  • For the quarter ending Q1 2026, EPS (Weighted Average and Diluted) rose 33.33% year-over-year to -$0.1; the trailing twelve-month figure through Mar 2026 stood at -$0.39 (up 39.06% YoY), and the FY2025 full-year result was -$0.44, up 41.33% from the prior year.
  • EPS (Weighted Average and Diluted) for Q1 2026 stood at -$0.1, down from -$0.04 in the prior quarter.
  • The five-year high for EPS (Weighted Average and Diluted) was -$0.04 in Q4 2025, with the low at -$0.54 in Q2 2022.
  • Average EPS (Weighted Average and Diluted) over 5 years is -$0.25, with a median of -$0.25 recorded in 2023.
  • Year-over-year, EPS (Weighted Average and Diluted) slumped 40.54% in 2022 and surged 63.64% in 2025.
  • Tracing SIBN's EPS (Weighted Average and Diluted) over 5 years: stood at -$0.32 in 2022, then gained by 15.63% to -$0.27 in 2023, then soared by 59.26% to -$0.11 in 2024, then surged by 63.64% to -$0.04 in 2025, then tumbled by 150.0% to -$0.1 in 2026.
  • The last three EPS (Weighted Average and Diluted) figures came in at -$0.1 (Q1 2026), -$0.04 (Q4 2025), and -$0.11 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Weighted Avg. Diluted) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 0.61
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 1.93
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 0.89
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 0.90
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 0.66
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 0.51
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 0.85
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 2.24
10 Si-Bone 611.92 Mn 471.80 Mn 41.94 Mn -0.10

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -0.10
Dec 31, 2025 -0.04
Sep 30, 2025 -0.11
Jun 30, 2025 -0.14
Mar 31, 2025 -0.15
Dec 31, 2024 -0.11
Sep 30, 2024 -0.16
Jun 30, 2024 -0.22
Mar 31, 2024 -0.27
Dec 31, 2023 -0.27
Sep 30, 2023 -0.25
Jun 30, 2023 -0.30
Mar 31, 2023 -0.32
Dec 31, 2022 -0.32
Sep 30, 2022 -0.41
Jun 30, 2022 -0.54
Mar 31, 2022 -0.52
Dec 31, 2021 -0.43
Sep 30, 2021 -0.48
Jun 30, 2021 -0.42
Mar 31, 2021 -0.37
Dec 31, 2020 -0.27
Sep 30, 2020 -0.33
Jun 30, 2020 -0.44